Get a glimpse into our company and investor data—powered by the PitchBook Platform
M&ALATEST DEAL TYPE
$7.9MLATEST DEAL AMOUNT
Developer of immunology-based assays designed to treat rheumatology and infectious diseases. The company is primarily engaged in developing diagnostic reagents and tests for infectious diseases and other protein targets.